doi.org
Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world Setting
August 2024 • Michael S. Leapman, Julian Ho, Yang Liu, Christopher P. Filson, Xin Zhao, Alexander Hakansson, J. Proudfoot, Elai Davicioni, Darryl T. Martin, Yi An,…
This study looked at the use of the Decipher genomic classifier, a test used to help understand the aggressiveness of a patient's prostate cancer. Looking at the results of 58 935 participants who underwent testing, we found that the Decipher test helped estimate the risk of cancer recurrence and metastasis.